Eutroxsig Side Effects
Generic name: levothyroxine
Medically reviewed by Drugs.com. Last updated on Mar 3, 2022.
Note: This document contains side effect information about levothyroxine. Some of the dosage forms listed on this page may not apply to the brand name Eutroxsig.
For the Consumer
Applies to levothyroxine: injection powder for solution
Side effects requiring immediate medical attention
Along with its needed effects, levothyroxine (the active ingredient contained in Eutroxsig) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking levothyroxine:
Incidence not known
- Fast heartbeat
- hives, itching, skin rash
- joint pain, stiffness, or swelling
- redness of the skin
- swelling of the eyelids, face, lips, hands, or feet
- tightness in the chest
- troubled breathing or swallowing
Get emergency help immediately if any of the following symptoms of overdose occur while taking levothyroxine:
- changes in menstrual periods
- chest pain, discomfort, or heaviness
- decreased urine output
- dilated neck veins
- excessive sweating
- extreme tiredness or weakness
- fast, pounding, or irregular heartbeat or pulse
- feeling of warmth
- hand tremors
- heat intolerance
- increased appetite
- leg cramps
- mood changes
- muscle weakness or spasm
- pain or discomfort in the arms, jaw, back, or neck
- sensitivity to heat
- stomach cramps
- trouble sleeping
- trouble sitting still
- weight gain or loss
For Healthcare Professionals
Applies to levothyroxine: compounding powder, injectable powder for injection, intravenous powder for injection, intravenous solution, oral capsule, oral solution, oral tablet
The more commonly reported adverse events have included those of hyperthyroidism due to therapeutic overdose including arrhythmias, myocardial infarction, dyspnea, muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite, weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash.
Cardiac function was evaluated in 20 patients requiring TSH suppression for either thyroid goiter or following thyroidectomy and radioactive iodine therapy for thyroid cancer and in 20 age and sex-matched controls. TSH suppression was associated with an increased incidence of premature ventricular beats, an increased left ventricular mass index, and enhanced left ventricular systolic function. The clinical significance of these changes remains to be determined.
Overtreatment with this drug may cause an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias, particularly in patients with cardiovascular disease and in elderly patients.[Ref]
Frequency not reported: Changes in symptom presentation for diabetes and adrenal cortical insufficiency[Ref]
A study evaluated the effect of long-term thyroid hormone therapy on bone mineral density in 196 women (mean age, 74.4 years) compared to a control group comprised of 795 women (mean age, 72.1 years). The mean daily thyroxine dose was 1.99 mcg/kg (range, 0.3 to 6.6 mcg/kg) with a mean duration of therapy of 20.4 years (range, less than 1 to 68 years). Women taking daily doses of 1.6 mcg/kg or more had significantly lower bone mineral density levels at the ultradistal radius, midshaft radius, hip, and lumbar spine compared to controls. However, estrogen use appeared to negate the adverse effects of thyroid hormone on bone mineral density.
Higher rates of femur fractures have been found in males (p=0.008) prescribed long-term thyroid hormone therapy as compared to controls in a case-control analysis of 23,183 patients, from the United Kingdom General Practice Research Database, prescribed thyroid hormone.
Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height.[Ref]
Frequency not reported: Diarrhea, vomiting, abdominal cramps[Ref]
Frequency not reported: Menstrual irregularities, impaired fertility[Ref]
Frequency not reported: Serum sickness, hypersensitivity to inactive ingredients[Ref]
Hypersensitivity reactions have occurred; however, it has been attributed to the inactive ingredients. These reactions have included urticaria, pruritus, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing. Hypersensitivity to levothyroxine itself is not known to occur.[Ref]
Frequency not reported: Increased appetite, weight loss[Ref]
Frequency not reported: Fatigue, heat intolerance, fever[Ref]
Frequency not reported: Nervousness, anxiety, irritability, emotional lability[Ref]
Frequently asked questions
- Does levothyroxine cause weight gain or loss?
- What happens if you stop taking levothyroxine?
- How soon after taking levothyroxine can I take omeprazole?
- What can I eat for breakfast after taking levothyroxine?
- Can I take other medications with levothyroxine?
- Does levothyroxine cause hair loss?
- Can I lay down after I take levothyroxine?
- How long after taking levothyroxine can you drink milk?
- How long does levothyroxine stay in your system?
- What is the difference between Levoxyl and Synthroid?
- Can you take thyroid supplements with levothyroxine?
- What is the difference between Unithroid and Synthroid?
- Can Euthyrox cause weight loss?
- Effect of not taking medicine after thyroid removal?
- Can Tirosint cause weight gain or loss?
More about Eutroxsig (levothyroxine)
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2)
- Drug class: thyroid drugs
Related treatment guides
1. Petersen K, Bengtason C, Lapidus L, et al. "Morbidity, mortality, and quality of life for patients treated with levothyroxine." Arch Intern Med 150 (1990): 2077-81
2. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC "Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH." Clin Endocrinol (Oxf) 37 (1992): 500-3
3. "Product Information. Synthroid (levothyroxine)." Abbott Pharmaceutical (2002):
4. Sheppard MC, Holder R, Franklyn JA "Levothyroxine treatment and occurrence of fracture of the hip." Arch Intern Med 162 (2002): 338-43
5. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
6. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. http://www.appco.com.au/appguide/default.asp." (2006):
Some side effects may not be reported. You may report them to the FDA.